Cargando…

Associations of human leukocyte antigen with neutralizing antibody titers in a tetravalent dengue vaccine phase 2 efficacy trial in Thailand

The recombinant, live, attenuated, tetravalent dengue vaccine CYD-TDV has shown efficacy against all four dengue serotypes. In this exploratory study (CYD59, NCT02827162), we evaluated potential associations of host human leukocyte antigen (HLA) alleles with dengue antibody responses, CYD-TDV vaccin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thomas, Rasmi, Chansinghakul, Danaya, Limkittikul, Kriengsak, Gilbert, Peter B., Hattasingh, Weerawan, Moodie, Zoe, Shangguan, Shida, Frago, Carina, Dulyachai, Wut, Li, Shuying Sue, Jarman, Richard G., Geretz, Aviva, Bouckenooghe, Alain, Sabchareon, Arunee, Juraska, Michal, Ehrenberg, Philip, Michael, Nelson L., Bailleux, Fabrice, Bryant, Chris, Gurunathan, Sanjay
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10536818/ https://www.ncbi.nlm.nih.gov/pubmed/34635391 http://dx.doi.org/10.1016/j.humimm.2021.09.006

Ejemplares similares

Dengue Infection in Children in Ratchaburi, Thailand: A Cohort Study. II. Clinical Manifestations
por: Sirivichayakul, Chukiat, et al.
Publicado: (2012)

Dengue Infection in Children in Ratchaburi, Thailand: A Cohort Study. I. Epidemiology of Symptomatic Acute Dengue Infection in Children, 2006–2009
por: Sabchareon, Arunee, et al.
Publicado: (2012)

Plaque reduction neutralization antibody test does not accurately predict protection against dengue infection in Ratchaburi cohort, Thailand
por: Sirivichayakul, Chukiat, et al.
Publicado: (2014)

Association between nutritional status and dengue severity in Thai children and adolescents
por: Te, Haypheng, et al.
Publicado: (2022)

Monoclonal antibody-based capture ELISA in the diagnosis of previous dengue infection
por: Sirivichayakul, Chukiat, et al.
Publicado: (2019)

Long-term immunogenicity and safety of tetravalent dengue vaccine (CYD-TDV) in healthy populations in Singapore and Vietnam: 4-year follow-up of randomized, controlled, phase II trials
por: Tran, Ngoc Huu, et al.
Publicado: (2019)

Integrated immunogenicity analysis of a tetravalent dengue vaccine up to 4 y after vaccination
por: Vigne, Claire, et al.
Publicado: (2017)

HLA-B*57 and B*58 Associate with Predictors of Reservoir Size in an Acutely Treated HIV Cohort
por: Shangguan, Shida, et al.
Publicado: (2023)

Antibody persistence upto 5 years after primary immunization and booster with an inactivated chromatographically purified Vero cell-derived Japanese encephalitis vaccine in Thai children
por: Hattasingh, Weerawan, et al.
Publicado: (2022)

Clinical and epidemiologic characteristics associated with dengue fever in 2011–2016 in Bang Phae district, Ratchaburi province, Thailand
por: Lim, Jacqueline Kyungah, et al.
Publicado: (2021)

Analysis of Hospitalized and Severe Dengue Cases Over the 6 years of Follow-up of the Tetravalent Dengue Vaccine (CYD-TDV) Efficacy Trials in Asia and Latin America
por: Forrat, Rémi, et al.
Publicado: (2021)

Immunogenicity and safety of inactivated chromatographically purified Vero cell-derived Japanese encephalitis vaccine in Thai children
por: Chanthavanich, Pornthep, et al.
Publicado: (2018)

Dengue seroprevalence: data from the clinical development of a tetravalent dengue vaccine in 14 countries (2005–2014)
por: L’Azou, Maïna, et al.
Publicado: (2018)

Five-Year Antibody Persistence Following a Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) Booster in JE-CV–Primed Children in the Philippines
por: Capeding, Maria Rosario, et al.
Publicado: (2018)

Dengue in Thailand and Cambodia: An Assessment of the Degree of Underrecognized Disease Burden Based on Reported Cases
por: Wichmann, Ole, et al.
Publicado: (2011)

High-throughput multiplex HLA genotyping by next-generation sequencing using multi-locus individual tagging
por: Ehrenberg, Philip K, et al.
Publicado: (2014)

Assessment of bivalent and tetravalent dengue vaccine formulations in flavivirus-naïve adults in Mexico
por: Dayan, Gustavo H, et al.
Publicado: (2014)

Serological Evidence of Japanese Encephalitis Virus Circulation in Asian Children From Dengue-Endemic Countries
por: Nealon, Joshua, et al.
Publicado: (2019)

Microneutralization assay titer correlates analysis in two phase 3 trials of the CYD-TDV tetravalent dengue vaccine in Asia and Latin America
por: Carpp, Lindsay N., et al.
Publicado: (2020)

Comparison of real-time SYBR green dengue assay with real-time taqman RT-PCR dengue assay and the conventional nested PCR for diagnosis of primary and secondary dengue infection
por: Paudel, Damodar, et al.
Publicado: (2011)

04. Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) Administered in Meningococcal Vaccine-Naive Participants Across a Broad Age Range (2-55 Years) in Japan
por: Matsuoka, Osamu, et al.
Publicado: (2021)

Modeling the long-term persistence of neutralizing antibody in children and toddlers after vaccination with live attenuated Japanese encephalitis chimeric virus vaccine
por: Bouckenooghe, Alain, et al.
Publicado: (2018)

Monocyte-derived transcriptome signature indicates antibody-dependent cellular phagocytosis as a potential mechanism of vaccine-induced protection against HIV-1
por: Shangguan, Shida, et al.
Publicado: (2021)

Epidemiological Trends of Dengue Disease in Thailand (2000–2011): A Systematic Literature Review
por: Limkittikul, Kriengsak, et al.
Publicado: (2014)

Humoral and cellular immunogenicity and safety following a booster dose of a tetravalent dengue vaccine 5+ years after completion of the primary series in Singapore: 2-year follow-up of a randomized phase II, placebo-controlled trial
por: Park, Juliana, et al.
Publicado: (2021)

Resource Use and Costs of Dengue: Analysis of Data from Phase III Efficacy Studies of a Tetravalent Dengue Vaccine
por: El Fezzazi, Hanna, et al.
Publicado: (2017)

Immunogenicity and safety of a tetravalent dengue vaccine in healthy adults in India: A randomized, observer-blind, placebo-controlled phase II trial
por: Dubey, Anand Prakash, et al.
Publicado: (2015)

Evaluation of Immunization Services for Children of Migrant Workers Along Thailand–Myanmar Border: Compliance with Global Vaccine Action Plan (2011–2020)
por: Pinna, Chamnan, et al.
Publicado: (2020)

The proxy dilemma: Informed consent in paediatric clinical research ‐ a case study of Thailand
por: Varadan, Sheila, et al.
Publicado: (2022)

Variations in HLA-B cell surface expression, half-life and extracellular antigen receptivity
por: Yarzabek, Brogan, et al.
Publicado: (2018)

Seroprevalence of Zika Virus in Amphawa District, Thailand, after the 2016 Pandemic
por: Sirinam, Salin, et al.
Publicado: (2022)

Impact of Dengue Vaccination on Serological Diagnosis: Insights From Phase III Dengue Vaccine Efficacy Trials
por: Plennevaux, Eric, et al.
Publicado: (2018)

Neutralizing Dengue Antibody in Pregnant Thai Women and Cord Blood
por: Khamim, Kriangsak, et al.
Publicado: (2015)

Perinatal Pandemic (H1N1) 2009 Infection, Thailand
por: Dulyachai, Wut, et al.
Publicado: (2010)

Acute Systemic Infection with Dengue Virus Leads to Vascular Leakage and Death through Tumor Necrosis Factor-α and Tie2/Angiopoietin Signaling in Mice Lacking Type I and II Interferon Receptors
por: Phanthanawiboon, Supranee, et al.
Publicado: (2016)

Risk Factors for Recurrent Abdominal Pain in Children with Nonorganic Acute Abdominal Pain
por: Piriyakitphaiboon, Varisa, et al.
Publicado: (2022)

Combining Immunoassays to Identify Zika Virus Infection in Dengue-Endemic Areas
por: Sittikul, Pichamon, et al.
Publicado: (2022)

Development and evaluation of a tetravalent botulinum vaccine
por: Shi, Dan-Yang, et al.
Publicado: (2022)

AP-1/c-Fos supports SIV and HIV-1 latency in CD4 T cells infected in vivo
por: Cobos Jiménez, Viviana, et al.
Publicado: (2023)

Characterization of B-cell and T-cell responses to a tetravalent dengue purified inactivated vaccine in healthy adults
por: Friberg, Heather, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_d94mad9csk1fku3ceton90rc30